Together, these findings establish that ADAM9 contributes to breast cancer cell survival via cell death inhibition and radioresistance while contributing to breast cancer cell progression via the promotion of proliferation, migration, and invasion. This evidence concerns the gene ADAM9 and breast carcinoma.